HCA Announces Proposed Public Offering of Senior Notes
January 17 2019 - 7:55AM
Business Wire
HCA Healthcare, Inc. (NYSE:HCA) today announced that its wholly
owned subsidiary, HCA Inc., proposes to offer $1.0 billion
aggregate principal amount of senior notes, subject to market and
other considerations. Actual terms of the notes, including interest
rate and principal amount, will depend on market conditions at the
time of pricing. HCA Inc. intends to use the net proceeds of this
offering for general corporate purposes, which may include
acquisitions.
UBS Investment Bank, Barclays, BofA Merrill Lynch, Citigroup,
Deutsche Bank Securities, Goldman Sachs & Co. LLC, J.P. Morgan,
Morgan Stanley, RBC Capital Markets, SMBC Nikko, SunTrust Robinson
Humphrey and Wells Fargo Securities are acting as the joint
book-running managers for the offering.
The offering of the notes is being made pursuant to an effective
shelf registration statement filed with the Securities and Exchange
Commission. The offering is being made only by means of a
preliminary prospectus supplement and the accompanying prospectus,
copies of which may be obtained from UBS Securities LLC, Attention:
Anna Mercatili, 1285 Avenue of the Americas, New York, NY 10019,
telephone: 203-719-3343, facsimile: 212-821-4043 or by emailing
anna.mercatili@ubs.com.
You may also visit www.sec.gov to obtain an electronic copy of
the prospectus and related preliminary prospectus supplement.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy, nor shall there be any sale of the
notes in any jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of any such jurisdiction.
FORWARD LOOKING STATEMENTS
Information provided and statements contained in this press
release that are not purely historical are forward-looking
statements within the meaning of Section 27A of the Securities Act,
Section 21E of the Exchange Act and the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements only
speak as of the date of this press release and HCA assumes no
obligation to update the information included in this press
release. Such forward-looking statements include the expected use
of proceeds from the offering. These statements often include words
such as “approximate,” “believe,” “expect,” “anticipate,” “intend,”
“plan,” “estimate” or similar expressions. These forward-looking
statements are not historical facts, and are based on current
expectations, estimates and projections about HCA’s industry,
management’s beliefs and certain assumptions made by management,
many of which, by their nature, are inherently uncertain and beyond
HCA’s control. Accordingly, readers are cautioned that any such
forward-looking statements are not guarantees of future performance
or occurrence of events and are subject to certain risks,
uncertainties and assumptions that are difficult to predict.
Although HCA believes that the expectations reflected in such
forward-looking statements are reasonable as of the date made,
expectations may prove to have been materially different from the
results expressed or implied by such forward-looking statements.
Unless otherwise required by law, HCA also disclaims any obligation
to update its view of any such risks or uncertainties or to
announce publicly the result of any revisions to the
forward-looking statements made in this press release.
All references to the “Company” and “HCA” as used throughout
this press release refer to HCA Healthcare, Inc. and its
affiliates.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190117005369/en/
INVESTOR CONTACT:Mark Kimbrough615-344-2688MEDIA
CONTACT:Ed Fishbough615-344-2810
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
From Aug 2024 to Sep 2024
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
From Sep 2023 to Sep 2024